Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03254953 · ClinicalTrials.gov registry record · NA
GoalTracker: Comparing Self-Monitoring Strategies for Weight Loss
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT03254953: Completed NA study, sponsored by Duke University.
NCT03254953 is a NA study that has completed, run by Duke University. The registered enrollment target is 105 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03254953, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
This study is a randomized controlled trial that compares 3 self-monitoring approaches for weight loss. GoalTracker is a standalone, technology-based intervention using a commercial smartphone app (MyFitnessPal) and email. The investigators hypothesize that the group that delays diet tracking and receives additional intervention components (weekly personalized feedback, skills training, and action plans) will have greater weight loss at the end of the 12-week intervention and at 6-month followup, compared to (a) an intervention group that simultaneously tracks weight and diet for all 12 weeks and receives the same additional components, and (b) a control group that tracks only diet.
Primary Outcome
Weight will be collected in kilograms using a calibrated digital scale
Interventions
- BEHAVIORAL self-monitoring of body weight
- BEHAVIORAL self-monitoring of diet
- BEHAVIORAL weekly personalized feedback + lessons + action plans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2017-04-19 |
| Est. Completion | 2018-03-02 |
| Phase | NA |
What the finished NCT03254953 record still lists
NCT03254953 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which self-monitoring of body weight is the first listed.
NCT03254953 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03254953 about?
NCT03254953 is a clinical study titled "GoalTracker: Comparing Self-Monitoring Strategies for Weight Loss". This study is a randomized controlled trial that compares 3 self-monitoring approaches for weight loss. GoalTracker is a standalone, technology-based intervention using a commercial smartphone app (MyFitnessPal) and email. The investigators hypothesize that the group that delays diet tracking and r...
What is the current status of trial NCT03254953?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2017-04-19. Estimated completion is 2018-03-02.
What interventions are being tested in trial NCT03254953?
The interventions under investigation include: self-monitoring of body weight (BEHAVIORAL), self-monitoring of diet (BEHAVIORAL), weekly personalized feedback + lessons + action plans (BEHAVIORAL).
Who is sponsoring clinical trial NCT03254953?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03254953's enrollment target sits among peer trials
105 834th of 2000 higher than 1,165 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI